Cover Image

Circulating tumor cells, from biotech innovation to clinical utility. Part B /

Circulating Tumor Cells, From Biotech Innovation to Clinical Utility Part B, Volume 392 in the International Review of Cell and Molecular Biology series, highlights new advances in the field, with this new volume presenting interesting chapters on a variety of timely topics, including Circulating Tu...

Full description

Bibliographic Details
Corporate Author: ScienceDirect (Online service)
Other Authors: Reduzzi, Carolina (Editor), Gerratana, Lorenzo (Editor), Cristofanilli, Massimo (Editor)
Format: eBook
Language:English
Published: London, United Kingdom ; Cambridge, MA ; San Diego, CA : Academic Press, an imprint of Elsevier, [2025]
Series:International review of cell and molecular biology ; Volume 392
Subjects:
Cells.
Cytology.
Molecular biology.
Tumor markers.
Cellules.
Cytologie.
Biologie moléculaire.
Marqueurs tumoraux.
molecular biology.
Electronic books.
Online Access:Connect to the full text of this electronic book
Description
Summary:Circulating Tumor Cells, From Biotech Innovation to Clinical Utility Part B, Volume 392 in the International Review of Cell and Molecular Biology series, highlights new advances in the field, with this new volume presenting interesting chapters on a variety of timely topics, including Circulating Tumor Cells in Lung Cancer: integrating stemness and heterogeneity to improve clinical utility, Multi-omic Features and Clustering Phenotypes of Circulating Tumor Cells Associated with Metastasis and Clinical Outcomes, CTCs in CRC: updates, Proteomics and post-translational modification analysis in CTCs, Latest advances of CTC studies in prostate cancer, and Epigenetics and CTCs: new biomarkers and impact on tumor biology.
Physical Description:1 online resource (x, 198 pages) : illustrations.
Bibliography:Includes bibliographical references at the end of each chapter.